{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T17:19:10Z","timestamp":1782321550250,"version":"3.54.5"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81402990"],"award-info":[{"award-number":["81402990"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012547","name":"Natural Science Foundation of Guangxi Zhuang Autonomous Region","doi-asserted-by":"publisher","award":["NZ14086"],"award-info":[{"award-number":["NZ14086"]}],"id":[{"id":"10.13039\/100012547","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.biopha.2017.08.126","type":"journal-article","created":{"date-parts":[[2017,9,15]],"date-time":"2017-09-15T22:46:10Z","timestamp":1505515570000},"page":"1161-1168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Protective effects of aloperin on monocroline-induced pulmonary hypertension via regulation of Rho A\/Rho kinsase pathway in rats"],"prefix":"10.1016","volume":"95","author":[{"given":"Fan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanxia","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinju","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2017.08.126_bib0005","first-page":"1219","article-title":"Treatment of pulmonary hypertension","volume":"31","author":"Hoeper","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.biopha.2017.08.126_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2016.07.003","article-title":"Physiological mechanisms of pulmonary hypertension","volume":"180","author":"Maciver","year":"2016","journal-title":"Am. Heart J."},{"issue":"5","key":"10.1016\/j.biopha.2017.08.126_bib0015","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/MCP.0000000000000192","article-title":"Right ventricle dysfunction in pulmonary hypertension: mechanisms and modes of detection","volume":"21","author":"Bourji","year":"2015","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"6","key":"10.1016\/j.biopha.2017.08.126_bib0020","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1183\/09031936.00046612","article-title":"Pathobiology of pulmonary arterial hypertension and right ventricular failure","volume":"40","author":"Voelkel","year":"2012","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.biopha.2017.08.126_bib0025","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10741-015-9519-2","article-title":"Molecular pathogenesis and current pathology of pulmonary hypertension","volume":"21","author":"Va","year":"2016","journal-title":"Heart Fail. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2017.08.126_bib0030","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1378\/chest.14-0862","article-title":"New molecular targets of pulmonary vascular remodeling in pulmonary arterial hypertension: importance of endothelial communication","volume":"147","author":"Guignabert","year":"2015","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.biopha.2017.08.126_bib0035","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1253\/circj.CJ-13-1586","article-title":"Role of endothelial nitric oxide synthase and collagen metabolism in right ventricular remodeling due to pulmonary hypertension","volume":"78","author":"Nergui","year":"2014","journal-title":"Circ. J."},{"issue":"4","key":"10.1016\/j.biopha.2017.08.126_bib0040","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.bbrc.2014.08.025","article-title":"Aloperine attenuated neuropathic pain induced by chronic constriction injury via anti-oxidation activity and suppression of the nuclear factor kappa B pathway","volume":"451","author":"Xu","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.biopha.2017.08.126_bib0045","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejphar.2009.12.007","article-title":"Effects and mechanisms of aloperine on 2, 4-dinitrofluorobenzene-induced allergic contact dermatitis in BALB\/c mice","volume":"629","author":"Yuan","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2017.08.126_bib0050","doi-asserted-by":"crossref","DOI":"10.2119\/molmed.2015.00056","article-title":"Aloperine protects mice against ischemia reperfusion (IR)-induced renal injury by regulating PI3 K\/AKT\/mTOR signaling and AP-1 activity","volume":"21","author":"Hu","year":"2015","journal-title":"Mol. Med."},{"issue":"1","key":"10.1016\/j.biopha.2017.08.126_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-015-0120-x","article-title":"Aloperine executes antitumor effects against multiple myeloma through dual apoptotic mechanisms","volume":"8","author":"Wang","year":"2015","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.biopha.2017.08.126_bib0060","article-title":"Protective effects of aloperine on myocardial injury induced by isoprenaline in rats","author":"Long","year":"1993","journal-title":"Chin. J. Pharmacol. Toxicol."},{"key":"10.1016\/j.biopha.2017.08.126_bib0065","article-title":"Tryptophan hydroxylase 1 (TPH1) inhibition impacts pulmonary vascular remodeling in two rat models of pulmonary hypertension","author":"Aiello","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2017.08.126_bib0070","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12931-016-0478-5","article-title":"Pulmonary hypertension and vascular remodeling in mice exposed to crystalline silica","volume":"17","author":"Zelko","year":"2016","journal-title":"Respir. Res."},{"issue":"1","key":"10.1016\/j.biopha.2017.08.126_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-014-0148-4","article-title":"Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats","volume":"15","author":"Yang","year":"2014","journal-title":"Respir. Res."},{"issue":"2","key":"10.1016\/j.biopha.2017.08.126_bib0080","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1253\/circj.70.174","article-title":"Beneficial acute effects of Rho-kinase inhibitor in patients with pulmonary arterial hypertension","volume":"70","author":"Ishikura","year":"2006","journal-title":"Circ. J."},{"issue":"9","key":"10.1016\/j.biopha.2017.08.126_bib0085","first-page":"1731","article-title":"Evidence for Rho-kinase activation in patients with pulmonary arterial hypertension","volume":"73","author":"Do","year":"2009","journal-title":"Circ. J. Off. J. Jpn. Circ. Soc."},{"issue":"2","key":"10.1016\/j.biopha.2017.08.126_bib0090","doi-asserted-by":"crossref","first-page":"H287","DOI":"10.1152\/ajpheart.00327.2011","article-title":"Rho-kinase: important new therapeutic target in cardiovascular diseases","volume":"301","author":"Satoh","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2017.08.126_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pupt.2010.09.001","article-title":"Key role of the RhoA\/Rho kinase system in pulmonary hypertension","volume":"24","author":"Connolly","year":"2011","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2017.08.126_bib0100","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2174\/157489012801227238","article-title":"Evaluation of clinical efficacy of fasudil for the treatment of pulmonary arterial hypertension","volume":"7","author":"Raja","year":"2012","journal-title":"Recent Pat. Cardiovasc. Drug Discov."},{"issue":"4","key":"10.1016\/j.biopha.2017.08.126_bib0105","first-page":"967","article-title":"Combination therapy with fasudil and sildenafil ameliorates monocrotaline-induced pulmonary hypertension and survival in rats","volume":"78","author":"Eliasalmamun","year":"2014","journal-title":"Circ. J. Off. J. Jpn. Circ. Soc."},{"issue":"2","key":"10.1016\/j.biopha.2017.08.126_bib0110","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jconrel.2013.01.011","article-title":"Liposomal Fasudil, a Rho-kinase inhibitor, for prolonged pulmonary preferential vasodilation in pulmonary arterial hypertension","volume":"167","author":"Gupta","year":"2013","journal-title":"J. Control. Release."},{"issue":"12","key":"10.1016\/j.biopha.2017.08.126_bib0115","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1021\/ja01315a073","article-title":"The isolation and some properties of an alkaloid from crotalaria spectabilis Roth 1","volume":"57","author":"Neal","year":"2002","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biopha.2017.08.126_bib0120","first-page":"13","article-title":"The relationship between reactivity of metabolites of pyrrolizidine alkaloids and extrahepatic toxicity","volume":"42","author":"Cooper","year":"1999","journal-title":"Proc. West. Pharmacol. Soc."},{"issue":"2","key":"10.1016\/j.biopha.2017.08.126_bib0125","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1081\/GNC-100107580","article-title":"Genotoxic pyrrolizidine alkaloids and pyrrolizidine alkaloid N-oxides\u2013mechanisms leading to DNA adduct formation and tumorigenicity","volume":"19","author":"Fu","year":"2001","journal-title":"J. Environ. Sci. Health C"},{"issue":"4","key":"10.1016\/j.biopha.2017.08.126_bib0130","doi-asserted-by":"crossref","first-page":"L363","DOI":"10.1152\/ajplung.00212.2011","article-title":"The monocrotaline model of pulmonary hypertension in perspective","volume":"302","author":"Gomezarroyo","year":"2011","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"5","key":"10.1016\/j.biopha.2017.08.126_bib0135","doi-asserted-by":"crossref","first-page":"H2424","DOI":"10.1152\/ajpheart.00369.2006","article-title":"Characterization of right ventricular function after monocrotaline-induced pulmonary hypertension in the intact rat","volume":"291","author":"Hessel","year":"2006","journal-title":"AJP Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2017.08.126_bib0140","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pupt.2015.09.007","article-title":"Exploring the monocrotaline animal model for the study of pulmonary arterial hypertension: a network approach","volume":"35","author":"Nogueira-Ferreira","year":"2015","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2017.08.126_bib0145","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1136\/thx.22.2.176","article-title":"Pulmonary hypertension produced in rats by ingestion of Crotalaria spectabilis seeds","volume":"22","author":"Kay","year":"1967","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.biopha.2017.08.126_bib0150","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.3892\/ijmm.2014.1718","article-title":"Aloperine induces G2\/M phase cell cycle arrest and apoptosis in HCT116 human colon cancer cells","volume":"33","author":"Zhang","year":"2014","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.biopha.2017.08.126_bib0155","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2147\/VHRM.S4711","article-title":"RhoA\/Rho-kinase signaling: a therapeutic target in pulmonary hypertension","volume":"5","author":"Barman","year":"2009","journal-title":"Vasc. Health Risk Manag."},{"issue":"4","key":"10.1016\/j.biopha.2017.08.126_bib0160","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/bjp.2008.239","article-title":"Therapeutic potential of RhoA\/Rho kinase inhibitors in pulmonary hypertension","volume":"155","author":"Oka","year":"2008","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2017.08.126_bib0165","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/157016309787581057","article-title":"The role of the RhoA\/rho-kinase pathway in pulmonary hypertension","volume":"6","author":"Nossaman","year":"2009","journal-title":"Curr. Drug Discov. Technol."},{"issue":"4","key":"10.1016\/j.biopha.2017.08.126_bib0170","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1517\/14728222.2012.671811","article-title":"Targeting RhoA\/ROCK pathway in pulmonary arterial hypertension","volume":"16","author":"Antoniu","year":"2012","journal-title":"Expert Opin. Ther. Targets"},{"issue":"30","key":"10.1016\/j.biopha.2017.08.126_bib0175","doi-asserted-by":"crossref","first-page":"29497","DOI":"10.18632\/oncotarget.4985","article-title":"Deoxypodophyllotoxin suppresses tumor vasculature in HUVECs by promoting cytoskeleton remodeling through LKB1-AMPK dependent Rho A activatio","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.biopha.2017.08.126_bib0180","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.vph.2012.12.003","article-title":"Heparin inhibits angiotensin II-induced vasoconstriction on isolated mouse mesenteric resistance arteries through Rho-A- and PKA-dependent pathways","volume":"58","author":"Xie-Zukauskas","year":"2013","journal-title":"Vasc. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2017.08.126_bib0185","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/01.RES.0000201960.04223.3c","article-title":"Rho kinases in cardiovascular physiology and pathophysiology","volume":"98","author":"Loirand","year":"2006","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.biopha.2017.08.126_bib0190","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1164\/rccm.200405-637OC","article-title":"Inhaled Rho kinase inhibitors are potent and selective vasodilators in rat pulmonary hypertension","volume":"171","author":"Nagaoka","year":"2012","journal-title":"Am. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.biopha.2017.08.126_bib0195","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s00380-009-1176-8","article-title":"Acute vasodilator effects of inhaled fasudil, a specific Rho-kinase inhibitor, in patients with pulmonary arterial hypertension","volume":"25","author":"Fujita","year":"2010","journal-title":"Heart Vessels"},{"issue":"4","key":"10.1016\/j.biopha.2017.08.126_bib0200","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1152\/ajplung.00090.2003","article-title":"Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase","volume":"287","author":"Fagan","year":"2004","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2017.08.126_bib0205","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1161\/01.RES.0000111804.34509.94","article-title":"Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats","volume":"94","author":"Abe","year":"2004","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.biopha.2017.08.126_bib0210","doi-asserted-by":"crossref","DOI":"10.1097\/HJH.0000000000000768","article-title":"Pathophysiological effects of RhoA and Rho-associated kinase on cardiovascular system","volume":"34","author":"Cai","year":"2015","journal-title":"J. Hypertens."},{"issue":"31","key":"10.1016\/j.biopha.2017.08.126_bib0215","doi-asserted-by":"crossref","first-page":"21926","DOI":"10.1074\/jbc.274.31.21926","article-title":"3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing rho GTPase-induced down-regulation of p27(Kip1)","volume":"274","author":"Laufs","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"17","key":"10.1016\/j.biopha.2017.08.126_bib0220","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1161\/01.CIR.101.17.2030","article-title":"Inhibition of rho-associated kinase results in suppression of neointimal formation of balloon-Injured arteries","volume":"101","author":"Sawada","year":"2000","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.biopha.2017.08.126_bib0225","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/01.HYP.0000153316.59262.79","article-title":"Role of Rho-kinase and p27 in angiotensin II-induced vascular injury","volume":"45","author":"Kanda","year":"2005","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.biopha.2017.08.126_bib0230","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/1465-9921-11-182","article-title":"Beta-estradiol attenuates hypoxic pulmonary hypertension by stabilizing the expression of p27kip1 in rats","volume":"11","author":"Xu","year":"2010","journal-title":"Respir. Res."},{"issue":"97","key":"10.1016\/j.biopha.2017.08.126_bib0235","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1161\/01.RES.0000188211.83193.1a","article-title":"Cyclin-dependent kinase inhibitor p27Kip1, but not p21WAF1\/Cip1, is required for inhibition of hypoxia-induced pulmonary hypertension and remodeling by heparin in mice","volume":"97","author":"Yu","year":"2005","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.biopha.2017.08.126_bib0240","first-page":"182","article-title":"The roles of bcl-2 gene family in the pulmonary artery remodeling of hypoxia pulmonary hypertension in rats","volume":"16","author":"Yang","year":"2001","journal-title":"Chin. Med. Sci. J."},{"issue":"12","key":"10.1016\/j.biopha.2017.08.126_bib0245","first-page":"1380","article-title":"Effects and mechanism of oridoninon pulmonary hypertension induced by chronic hypoxia-hypercapnia in rats","volume":"122","author":"Wang","year":"2009","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.biopha.2017.08.126_bib0250","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.yjmcc.2015.03.005","article-title":"Salidroside attenuates chronic hypoxia-induced pulmonary hypertension via adenosine A2a receptor related mitochondria-dependent apoptosis pathway","volume":"82","author":"Huang","year":"2015","journal-title":"J. Mol. Cell. Cardiol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217312787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217312787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T08:00:49Z","timestamp":1771401649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217312787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":50,"alternative-id":["S0753332217312787"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.08.126","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective effects of aloperin on monocroline-induced pulmonary hypertension via regulation of Rho A\/Rho kinsase pathway in rats","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.08.126","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}